Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cerevel Therapeutics Holdings Inc CERE

Healthcare Biotechnology
Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on neuroscience that combines an understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) target receptor selective pharmacology to discover and design new therapies. It focuses on transform the lives of patients... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CERE)

BUYOUT INVESTIGATION ALERT: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings, Inc. (CERE) and Encourages Investors to Contact the Firm

Accesswire 2 days ago

Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson's Disease

GlobeNewswire April 18, 2024

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates MGRC, SNCE, VINE, CERE

PR Newswire January 29, 2024

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates CSTR, CERE, PGTI, FGH

Accesswire January 27, 2024

CEREVEL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cerevel Therapeutics - CERE

PR Newswire January 26, 2024

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Cerevel Therapeutics Holdings, Inc. (CERE)

Newsfile January 26, 2024

Kuehn Law Encourages MDC, WAVD, NS and CERE Investors to Contact Law Firm

PR Newswire January 24, 2024

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates CSTR, SIX, CERE, EGLE

PR Newswire January 23, 2024

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Cerevel Therapeutics Holdings, Inc. (CERE)

Newsfile January 22, 2024
View More News ››

Opinion & Analysis (NDAQ:CERE)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CERE)

New everyday - cant believe this is not @ a 1$

Ceres Sugarcane Traits Approved for Field Testing in Brazil 07:15 ET from Ceres, Inc. THOUSAND OAKS, Calif., April 28, 2016...
Conradsparrow - April 28, 2016
View more Bullboard ››

Fokus Mining Corp

Fokus Mining Corp

Fokus Mining Corporation is a Canada-based mineral resource company. The Company is engaged in acquiring, exploring and ...
View More »